Can early use of Salmeterol/Fluticasone control childhood asthma better than Fluticasone alone in long-term management?

Can early use of Salmeterol/Fluticasone control childhood asthma better than Fluticasone alone in long-term management? - The effectiveness of early intervention with Salmeterol/Fluticasone in childhood asthma.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000010219

Enrollment

Registered

2013-03-13

Start date

2012-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

childhood asthma

Interventions

Salmeterol/fluticasone (SFC) group fluticasone (FC) group

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The asthmatics between 4-11 years old of age, treated for 12weeks with LTRA treatment , and who is not well-controlled.

Exclusion criteria

Exclusion criteria: The patient who have : 1. congenital heart disease 2. chronic lung disease, or congenital lung disease. 3. premature baby born less than 34week 4. congenital annormaly 5. already using oral steroid 6 allergy to beta stimulants or inhaled steroid

Design outcomes

Primary

Measure	Time frame
1. The difference between total control ratio in SFC and FP in 12 weeks. 2. The difference between total control length in SFC and FP after 13 weeks.	—

Secondary

Measure	Time frame
1. The difference of improvement of inhaled NO and pulmonary function in SFC and FP. 2. The difference of use of full agonist of beta stimulant in SFC and FP.	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026